273 related articles for article (PubMed ID: 8598490)
1. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
[TBL] [Abstract][Full Text] [Related]
3. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
[TBL] [Abstract][Full Text] [Related]
4. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
[No Abstract] [Full Text] [Related]
6. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
[TBL] [Abstract][Full Text] [Related]
7. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
9. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
Onodera K; Hancock WW; Graser E; Lehmann M; Sayegh MH; Strom TB; Volk HD; Kupiec-Weglinski JW
J Immunol; 1997 Feb; 158(4):1572-81. PubMed ID: 9029092
[TBL] [Abstract][Full Text] [Related]
10. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
[No Abstract] [Full Text] [Related]
13. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
[TBL] [Abstract][Full Text] [Related]
14. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
[TBL] [Abstract][Full Text] [Related]
15. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1995 Feb; 59(4):590-7. PubMed ID: 7878763
[TBL] [Abstract][Full Text] [Related]
16. The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation.
McDiarmid SV; Farmer DG; Kuniyoshi JS; Robert M; Khadavi A; Shaked A; Busuttil RW
Transplantation; 1994 Sep; 58(6):690-7. PubMed ID: 7940688
[TBL] [Abstract][Full Text] [Related]
17. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts.
O'Connell PJ; Pacheco-Silva A; Nickerson PW; Muggia RA; Bastos M; Kelley VR; Strom TB
J Immunol; 1993 Feb; 150(3):1093-104. PubMed ID: 8423334
[TBL] [Abstract][Full Text] [Related]
18. Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
Papp I; Wieder KJ; Sablinski T; O'Connell PJ; Milford EL; Strom TB; Kupiec-Weglinski JW
J Immunol; 1992 Mar; 148(5):1308-14. PubMed ID: 1347048
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
